The results showed that the downregulation of KIF-12 expression enhances the progression of differentiated thyroid carcinoma, and the effect may be more significant among younger female patients with unifocal PTC showing lymph node metastasis and BRAF mutation. The gene discussed is BRAF; the disease is differentiated thyroid carcinoma.